Thanks to this Postgraduate diploma you will improve your knowledge in advanced skin biology for a more efficient diagnosis of cancerous pathologies"

Recent studies have shown that patients with Gardner Syndrome have a higher probability of developing Basal Cell Carcinoma, Squamous Cell Carcinoma and Malignant Melanoma compared to the general population. This is due to the presence of inherited genetic mutations that affect cell growth regulation and DNA repair. For this reason, it is important for the clinical specialists to be constantly informed of the latest scientific evidence that allows them to be up to date with the latest diagnostic techniques, evaluation, treatment and prevention of this pathology and other similar diseases.

In this sense, TECH has designed this program that allows the professional to experience an adequate education about the risk factors of Skin Cancer. This way, the clinical specialist will deepen in hereditary diseases with cutaneous manifestations, oral cavity squamous cell carcinoma, Kaposi's sarcoma and other cutaneous neoplasms. Likewise, they will expand their knowledge of diagnostic tests in skin cancer, dermoscopy and molecular biology techniques.

Also, this Postgraduate diploma provides versatility, which will allow the physician to access its content at any time and location. In addition, this curriculum incorporates in its teaching methodology the Relearning system, which facilitates the consolidation of the most important concepts in a faster way. All this, accompanied by a variety of pedagogical resources such as real case studies and video summaries stored inb a virtual library with unlimited access from any device connected to the network.

You will identify and evaluate the most recurrent Risk Factors for Skin Cancer such as skin photo-types and chemical exposure"

This Postgraduate diploma in Risk Factors for Skin Cancer contains the most complete and up-to-date scientific program on the market. The most important features include:

• The development of case studies presented by experts in Dermatology, Oncology and Plastic and Reconstructive Surgery
• The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice
• Practical exercises where the self-assessment process can be carried out to improve learning
• Its special emphasis on innovative methodologies
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection 

An academic option that will allow you to stay ahead of advances in nucleic acid hybridization techniques"

The program's teaching staff includes professionals from the sector who contribute their work experience to this program, in addition to renowned specialists from leading societies and prestigious universities.

Its multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide an immersive education programmed to learn in real situations.

The design of this program focuses on Problem-Based Learning, by means of which the professional must try to solve the different professional practice situations that are presented throughout the academic course. For this purpose, the student will be assisted by an innovative interactive video system created by renowned experts.

With this 100% online program you will address the different types of Skin Cancer from Melanoma to unrelated diseases"

You will be up to date on the clinical signs that could make the difference in the early diagnosis of skin cancer"

This Postgraduate diploma brings together the most relevant concepts about the Risk Factors for Skin Cancer. This way, the professionals will obtain an extensionin their knowledge and will deepen in identifying the people who have a higher risk of developing Skin Cancer and to take preventive measures and to elaborate diagnostic tests for this pathology. In addition, it will delve into the classification, diagnosis and treatment of other cutaneous neoplasms. All this, with a series of multimedia resources housed in a virtual library that can be accessed from anywhere without time restrictions.

With the Relearning method you will remember information more effectively and without investing long hours in this learning process"

Module 1. Skin Cancer

1.1. Advanced skin biology

1.1.1. Skin Anatomy
1.1.2. Functions of the Skin
1.1.3. Structural characteristics of the skin
1.1.4. Epidermis, Dermis, Hypodermis, Skin appendages

1.2. Genetics of skin cancer

1.2.1. Analysis of the genetics of skin cancer
1.2.2. Heredity and risk
1.2.3. Genes associated with skin cancer
1.2.4. Syndromes associated with Skin Cancer
1.2.5. Other genes with possible susceptibility in Melanoma

1.3. Risk Factors

1.3.1. Description of risk factors
1.3.2. Skin photo-types
1.3.3. Radiation exposure
1.3.4. Exposure to certain chemicals

1.4. Prevention of skin cancer

1.4.1. Evaluation of skin cancer prevention
1.4.2. Photo protection
1.4.3. Sunscreens
1.4.4. Other Measures

1.5. Classification

1.5.1. Non-Melanoma Skin Cancer
1.5.2. Basal Cell Carcinoma
1.5.3. Squamous cell carcinoma of the skin
1.5.4. Melanoma

1.6. Clinical signs and symptoms

1.6.1. Signs and symptoms of basal cell carcinoma.
1.6.2. Signs and symptoms of squamous cell carcinoma
1.6.3. Signs and symptoms of Melanoma
1.6.4. Signs and symptoms of less common types of skin cancer

1.7. Diagnostic tests in skin cancer

1.7.1. Analysis of diagnostic tests in Skin Cancer
1.7.2. Confocal reflectance microscopy
1.7.3. Biopsies
1.7.4. Skin ultrasound

1.8. Dermatoscopy

1.8.1. Analysis of dermoscopy of hyperpigmented lesions.
1.8.2. Description of the dermoscopic parameters used in the 3-point rule and the BLINCK algorithm
1.8.3. Dermatoscopic diagnostic procedure
1.8.4. Three-point rule

1.9. Margin study method

1.9.1. Considerations on the margins of lateral and deep resection in the pieces of skin tumor excision
1.9.2. Evaluation of the surgical margins of basal cell carcinoma.dermoscopic
1.9.3. Evaluation of Melanoma margins

1.10. Molecular Biology Techniques

1.10.1. Evaluation of molecular biology techniques
1.10.2. Molecular biology in dermatological diagnostics
1.10.3. Obtaining DNA/RNA
1.10.4. Nucleic acid hybridization techniques

Module 2. Other Skin Neoplasms

2.1. Evaluation of other skin neoplasms

2.1.1. Classification of other skin neoplasms
2.1.2. Staging of other skin neoplasms
2.1.3. Diagnosis of other skin neoplasms

2.2. Oral cavity squamous cell carcinoma

2.2.1. Analysis of squamous cell carcinoma of the oral cavity
2.2.2. Histopathology of oral cavity squamous cell carcinoma
2.2.3. Diagnosis of oral cavity squamous cell carcinoma
2.2.4. Treatment of squamous cell carcinoma of the oral cavity

2.3. Penile squamous cell carcinoma

2.3.1. Evaluation of penile squamous cell carcinoma
2.3.2. Histopathology of penile squamous cell carcinoma
2.3.3. Diagnosis of penile squamous cell carcinoma
2.3.4. Treatment of penile squamous cell carcinoma

2.4. Anal squamous carcinoma

2.4.1. Analysis of anal squamous cell carcinoma
2.4.2. Histopathology of anal squamous cell carcinoma
2.4.3. Diagnosis of anal squamous cell carcinoma
2.4.4. Treatment of anal squamous cell carcinoma

2.5. Kaposi's Sarcoma

2.5.1. Evaluation of Kaposi's sarcoma
2.5.2. Histopathology of Kaposi's Sarcoma
2.5.3. Diagnosis of Kaposi's sarcoma
2.5.4. Treatment of Kaposi's sarcoma

2.6. Leukoplakia

2.6.1. Analysis of Leukoplakia
2.6.2. Histopathology of Leukoplakia
2.6.3. Diagnosis of Leukoplakia
2.6.4. Treatment of leukoplakia

2.7. Keratoacanthomas

2.7.1. Evaluation of Keratoacanthomas
2.7.2. Histopathology of keratoacanthomas
2.7.3. Diagnosis of Keratoacanthomas
2.7.4. Treatment of keratoacanthomas

2.8. Invasive Paget’s Disease

2.8.1. Analysis of extramammary Paget's disease
2.8.2. Histopathology of extramammary Paget's disease
2.8.3. Diagnosis of extramammary Paget disease
2.8.4. Treatment of extramammary Paget disease

2.9. Malignant subcutaneous or soft-tissue tumors (sarcomas)

2.9.1. Dermatofibrosarcoma
2.9.2. Leiomyosarcomas
2.9.3. Rhabdomyosarcoma
2.9.4. Liposarcomas

2.10. Epidermal lesions

2.10.1. Actinic Keratosis
2.10.2. Bowen's Disease
2.10.3. Spitzoid lesions

Module 3. Genodermatoses Predisposing to Skin Cancer

3.1. Neurofibromatosis

3.1.1. Analysis of Neurofibromatosis
3.1.2. Clinical features of neurofibromatosis
3.1.3. Histopathology features of neurofibromatosis
3.1.4. Treatment in neurofibromatosis

3.2. Tuberous Sclerosis

3.2.1. Tuberous Sclerosis Evaluation
3.2.2. Clinical manifestations of Tuberous Sclerosis
3.2.3. Histopathology manifestations of Tuberous Sclerosis
3.2.4. Treatment in tuberous sclerosis

3.3. Pseudoxanthoma elasticum

3.3.1. Analysis of the elastic pseudoxanthoma
3.3.2. Clinical features in Pseudoxanthoma elasticum
3.3.3. Histopathology features in Pseudoxanthoma elasticum
3.3.4. Treatment in pseudoxanthoma elasticum

3.4. Ehlers-Danlos Syndrome

3.4.1. Evaluation of Ehlers-Danols syndrome.
3.4.2. Clinical features of Ehlers-Danols syndrome
3.4.3. Histopathology in Ehlers-Danols syndrome
3.4.4. Treatment in Ehlers-Danols syndrome

3.5. Muir-Torre syndrome

3.5.1. Analysis of the Muir-Torre Syndrome
3.5.2. Muir-Torre Syndrome Clinic
3.5.3. Histopathology in Muir-Torre Syndrome
3.5.4. Treatment in Muir-Torre Syndrome

3.6. Gorlin or nevoid basal cell carcinoma syndrome

3.6.1. Evaluation of Gorlin's syndrome or nevoid basal cell carcinoma
3.6.2. Clinical features of Gorlin's syndrome or nevoid basal cell carcinoma
3.6.3. Histopathology features of Gorlin's syndrome or nevoid basal cell carcinoma
3.6.4. Treatment in Gorlin's Syndrome or nevoid basal cell carcinoma

3.7. Cowden's syndrome (multiple hamartomas)

3.7.1. Analysis of Cowden syndrome (multiple Hamartomas)
3.7.2. Clinic in Cowden syndrome (multiple Hamartomas)
3.7.3. Histopathology in Cowden's syndrome (multiple Hamartomas)
3.7.4. Treatment in Cowden's syndrome (multiple Hamartomas)

3.8. Gardner syndrome

3.8.1. Evaluation of Gardner's Syndrome
3.8.2. Clinical features of Gardner's syndrome
3.8.3. Histopathology in Gardner's Syndrome
3.8.4. Treatment in Gardner syndrome

3.9. Pigmentovascular phakomatosis associated with hypochromic nevus

3.9.1. Evaluation of pigmentovascular phakomatosis associated with hypochromic nevus.
3.9.2. Clinical features of Pigmentovascular phakomatosis associated with hypochromic nevus
3.9.3. Histopathology features of Pigmentovascular phakomatosis associated with hypochromic nevus
3.9.4. Treatment features of Pigmentovascular phakomatosis associated with hypochromic nevus

3.10. Congenital pachyonychia in multiple family members

3.10.1. Analysis of Pachyonychia congenita
3.10.2. Clinical features of pachyonychia congenita
3.10.3. Histopathology in Pachyonychia congenita
3.10.4. Treatment in Pachyonychia congenita

You will explore advances in the treatments of Cowden Syndrome, Ehlers-Danlos Syndrome and Pseudoxanthoma elasticum”